Guardant Health: chief legal officer John G. Saia exercised 7,063 shares

What happened

• John G. Saia, chief legal officer, exercised or converted derivatives into 7,063 shares on Oct 1, 2026 (entries show exercise/conversion at $0.00).
• The company withheld 3,706 shares to satisfy tax withholding at $174.75 per share for a total of $647,624; the remaining 3,357 shares were issued to Mr. Saia.

Key details

• Transaction date: Oct 1, 2026. Exercise price/derivative conversion price: $0.00 for the 7,063 shares; tax withholding price: $174.75 for 3,706 shares.
• Shares received after withholding: 3,357 shares. The filing does not state total shares owned by the insider after the transaction.
• Relevant footnotes: F1 indicates the company retained shares to meet the award-holder’s tax withholding obligations; F2–F6 describe the restricted stock unit awards and their vesting schedules (awarded Nov 7, 2022; Dec 13, 2023; Nov 8, 2024; Mar 12, 2025 with multi-year vesting).
• Transaction codes in the filing: M = exercise/conversion of derivative; F = payment of tax liability via share withholding.
• Filed on Oct 2, 2026 (timely).

Why it may matter

• The filing shows restricted stock units vested and were converted to shares; 3,706 shares were withheld by the company to cover tax withholding (a sell-to-cover style withholding) and 3,357 shares were issued to the insider.
• The filing does not show why the insider traded or why the company acted.